The Outlook On Drug Pricing And Surprise Billing In Congress

Law360 (August 14, 2019, 1:36 PM EDT) -- Recent months have seen a flurry of activity in Congress on prescription drug pricing and surprise medical bills as lawmakers seek to address rising consumer health care costs. House and Senate committees have advanced legislation on drug pricing and surprise billing, and additional activity is expected in September following the August recess, including possible floor action.

Drug Pricing

See a table summarizing drug pricing legislation and administrative actions here.

Several Senate committees of jurisdiction have advanced drug pricing legislation in recent months, taking different approaches to the issue. On June 26, the Senate Health, Education, Labor and Pensions Committee advanced its...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS